Saliva biomarkers for predicting outcome in pediatric and adult patients with severe and moderate TBI
IC Name
NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL
-
Activity
R43
-
Administering IC
CE
-
Application Type
6
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
225000
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
-
Ed Inst. Type
-
Funding ICs
-
Funding Mechanism
SBIR-STTR RPGs
-
Study Section
ZRG1
-
Study Section Name
Special Emphasis Panel